• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分析针对白血病细胞产生的一组新的 IgM 和 IgG1 单克隆抗体的 Tn 抗原性。

Analysis of Tn antigenicity with a panel of new IgM and IgG1 monoclonal antibodies raised against leukemic cells.

机构信息

Copenhagen Center for Glycomics, Department of Cellular and Molecular Medicine, University of Copenhagen, Blegdamsvej 3, dept. 24.6.48, DK-2200 N Copenhagen, Denmark.

出版信息

Glycobiology. 2012 Apr;22(4):529-42. doi: 10.1093/glycob/cwr178. Epub 2011 Dec 5.

DOI:10.1093/glycob/cwr178
PMID:22143985
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3287017/
Abstract

CD175 or Tn antigen is a carbohydrate moiety of N-acetylgalactosamine (GalNAc)α1-O- linked to the residue of amino acid serine or threonine in a polypeptide chain. Despite the chemical simplicity of the Tn antigen, its antigenic structure is considered to be complex and the clear determinants of Tn antigenicity remain poorly understood. As a consequence, a broad variety of anti-Tn monoclonal antibodies (mAbs) have been generated. To further investigate the nature and complexity of the Tn antigen, we generated seven different anti-Tn mAbs of IgM and IgG classes raised against human Jurkat T cells, which are Tn-positive due to the low activity of T-synthase and mutation in specific chaperone Cosmc. The binding analysis of anti-Tn mAbs with the array of synthetic saccharides, glycopeptides and O-glycoproteins revealed unexpected differences in specificities of anti-Tn mAbs. IgM mAbs bound the terminal GalNAc residue of the Tn antigen irrespective of the peptide context or with low selectivity to the glycoproteins. In contrast, IgG mAbs recognized the Tn antigen in the context of a specific peptide motif. Particularly, JA3 mAb reacted to the GSPP or GSPAPP, and JA5 mAb recognized specifically the GSP motif (glycosylation sites are underlined). The major O-glycan carrier proteins CD43 and CD162 and isoforms of CD45 expressed on Jurkat cells were precipitated by anti-Tn mAbs with different affinities. In summary, our data suggest that Tn antigen-Ab binding capacity is determined by the peptide context of the Tn antigen, antigenic specificity of the Ab and class of the immunoglobulin. The newly generated anti-Tn IgG mAbs with the strong specificity to glycoprotein CD43 can be particularly interesting for the application in leukemia diagnostics and therapy.

摘要

CD175 或 Tn 抗原是 N-乙酰半乳糖胺 (GalNAc)α1-O-连接到多肽链中丝氨酸或苏氨酸残基上的碳水化合物部分。尽管 Tn 抗原的化学结构简单,但它的抗原结构被认为是复杂的,并且 Tn 抗原性的明确决定因素仍知之甚少。因此,产生了广泛的抗 Tn 单克隆抗体 (mAb)。为了进一步研究 Tn 抗原的性质和复杂性,我们针对 Tn 阳性的人类 Jurkat T 细胞产生了七种不同的 IgM 和 IgG 类抗 Tn mAb,这是由于 T-合成酶活性低和特定伴侣 Cosmc 突变所致。抗 Tn mAb 与一系列合成糖、糖肽和 O-糖蛋白的结合分析揭示了抗 Tn mAb 特异性的意外差异。IgM mAb 结合 Tn 抗原的末端 GalNAc 残基,无论肽结构如何,其结合特异性都较低,或者对糖蛋白的结合特异性较低。相比之下,IgG mAb 在特定肽基序的背景下识别 Tn 抗原。特别是,JA3 mAb 与 GSPP 或 GSPAPP 反应,而 JA5 mAb 特异性识别 GSP 基序(糖基化位点用下划线表示)。Jurkat 细胞上表达的主要 O-聚糖载体蛋白 CD43 和 CD162 以及 CD45 同工型被抗 Tn mAb 以不同的亲和力沉淀。总之,我们的数据表明,Tn 抗原-Ab 结合能力取决于 Tn 抗原的肽结构、Ab 的抗原特异性和免疫球蛋白的类别。具有强特异性的新型抗 Tn IgG mAb 对 CD43 糖蛋白在白血病诊断和治疗中的应用特别有趣。

相似文献

1
Analysis of Tn antigenicity with a panel of new IgM and IgG1 monoclonal antibodies raised against leukemic cells.分析针对白血病细胞产生的一组新的 IgM 和 IgG1 单克隆抗体的 Tn 抗原性。
Glycobiology. 2012 Apr;22(4):529-42. doi: 10.1093/glycob/cwr178. Epub 2011 Dec 5.
2
Monoclonal antibodies toward different Tn-amino acid backbones display distinct recognition patterns on human cancer cells. Implications for effective immuno-targeting of cancer.针对不同 Tn-氨基酸骨架的单克隆抗体在人类癌细胞上显示出不同的识别模式。对癌症有效免疫靶向的影响。
Cancer Immunol Immunother. 2013 Jun;62(6):1107-22. doi: 10.1007/s00262-013-1425-7. Epub 2013 Apr 21.
3
Mouse-human chimeric anti-Tn IgG1 induced anti-tumor activity against Jurkat cells in vitro and in vivo.小鼠-人嵌合抗Tn IgG1在体外和体内均诱导了针对Jurkat细胞的抗肿瘤活性。
Biol Pharm Bull. 2008 Sep;31(9):1739-44. doi: 10.1248/bpb.31.1739.
4
Role of O-glycosylation and expression of CD43 and CD45 on the surfaces of effector T cells in human T cell leukemia virus type 1 cell-to-cell infection.效应 T 细胞表面 O-糖基化和 CD43、CD45 的表达在人类 T 细胞白血病病毒 1 细胞间感染中的作用。
J Virol. 2012 Mar;86(5):2447-58. doi: 10.1128/JVI.06993-11. Epub 2011 Dec 14.
5
Specificity analysis of murine monoclonal antibodies reactive with Tn, sialylated Tn, T, and monosialylated (2-->6) T antigens.与Tn、唾液酸化Tn、T以及单唾液酸化(2→6)T抗原反应的鼠单克隆抗体的特异性分析
Hybridoma. 1996 Dec;15(6):401-8. doi: 10.1089/hyb.1996.15.401.
6
Early ovariectomy reveals the germline encoding of natural anti-A- and Tn-cross-reactive immunoglobulin M (IgM) arising from developmental O-GalNAc glycosylations. (Germline-encoded natural anti-A/Tn cross-reactive IgM).早期卵巢切除术揭示了由发育性O-连接N-乙酰半乳糖胺糖基化产生的天然抗A和抗Tn交叉反应性免疫球蛋白M(IgM)的种系编码。(种系编码的天然抗A/抗Tn交叉反应性IgM)
Cancer Med. 2017 Jul;6(7):1601-1613. doi: 10.1002/cam4.1079. Epub 2017 Jun 5.
7
Specificity of human natural antibodies referred to as anti-Tn.人源天然抗体(称为抗-Tn)的特异性。
Mol Immunol. 2020 Apr;120:74-82. doi: 10.1016/j.molimm.2020.02.005. Epub 2020 Feb 19.
8
COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer.COSMC基因敲低介导的异常O-糖基化促进胰腺癌的致癌特性。
Mol Cancer. 2015 May 29;14:109. doi: 10.1186/s12943-015-0386-1.
9
Structurally defined synthetic cancer vaccines: analysis of structure, glycosylation and recognition of cancer associated mucin, MUC-1 derived peptides.结构明确的合成癌症疫苗:癌症相关粘蛋白MUC-1衍生肽的结构、糖基化及识别分析
Glycoconj J. 1995 Oct;12(5):607-17. doi: 10.1007/BF00731254.
10
An essential epitope of anti-MUC1 monoclonal antibody KL-6 revealed by focused glycopeptide library.通过聚焦糖肽文库揭示抗 MUC1 单克隆抗体 KL-6 的一个必需表位。
J Am Chem Soc. 2009 Dec 2;131(47):17102-9. doi: 10.1021/ja903361f.

引用本文的文献

1
Structure-guided phage display discovery of antibodies for (S)Tn-glycans in protein context.在蛋白质环境中通过结构引导的噬菌体展示发现针对(S)Tn聚糖的抗体。
Nat Chem Biol. 2025 Jul 31. doi: 10.1038/s41589-025-01971-8.
2
Anti-GalNAcα (anti-Tn) antibody repertoire differs between individuals with blood groups A and B.血型A和B个体之间的抗N-乙酰半乳糖胺α(抗Tn)抗体库有所不同。
Glycoconj J. 2025 Apr 26. doi: 10.1007/s10719-025-10184-z.
3
Mammalian cell-based production of glycans, glycopeptides and glycomodules.哺乳动物细胞糖基化产物、糖肽和糖基化修饰模块的生产。
Nat Commun. 2024 Nov 8;15(1):9668. doi: 10.1038/s41467-024-53738-9.
4
Detecting PTP Protein-Protein Interactions by Fluorescent Immunoprecipitation Analysis (FIPA).通过荧光免疫沉淀分析(FIPA)检测 PTP 蛋白-蛋白相互作用。
Methods Mol Biol. 2024;2743:181-194. doi: 10.1007/978-1-0716-3569-8_12.
5
Aberrant Glycosylation as Immune Therapeutic Targets for Solid Tumors.异常糖基化作为实体瘤的免疫治疗靶点
Cancers (Basel). 2023 Jul 8;15(14):3536. doi: 10.3390/cancers15143536.
6
Targeting Tumor Glycans for Cancer Therapy: Successes, Limitations, and Perspectives.靶向肿瘤聚糖用于癌症治疗:成功、局限与展望
Cancers (Basel). 2022 Jan 27;14(3):645. doi: 10.3390/cancers14030645.
7
Synthesis of -linked α-Gal and α-GalNAc-1'-hydroxyalkanes by way of C2 functionality transfer.通过C2官能团转移合成连接的α-半乳糖和α- N -乙酰半乳糖胺-1'-羟基烷烃。
Tetrahedron Lett. 2021 Jun 8;73. doi: 10.1016/j.tetlet.2021.153109. Epub 2021 Apr 23.
8
When Glycosylation Meets Blood Cells: A Glance of the Aberrant Glycosylation in Hematological Malignancies.当糖基化遇到血细胞:血液系统恶性肿瘤中异常糖基化的一瞥。
Rev Physiol Biochem Pharmacol. 2021;180:85-117. doi: 10.1007/112_2021_60.
9
40 years of glyco-polyacrylamide in glycobiology.糖生物学领域中糖基化聚丙烯酰胺的40年发展历程。
Glycoconj J. 2021 Feb;38(1):89-100. doi: 10.1007/s10719-020-09965-5. Epub 2021 Jan 14.
10
Identification of Tn antigen O-GalNAc-expressing glycoproteins in human carcinomas using novel anti-Tn recombinant antibodies.使用新型抗 Tn 重组抗体鉴定人癌中的 Tn 抗原 O-GalNAc 表达糖蛋白。
Glycobiology. 2020 Apr 20;30(5):282-300. doi: 10.1093/glycob/cwz095.

本文引用的文献

1
A new murine IgG1 anti-Tn monoclonal antibody with in vivo anti-tumor activity.一种具有体内抗肿瘤活性的新型鼠 IgG1 抗 Tn 单克隆抗体。
Glycobiology. 2011 Aug;21(8):1097-107. doi: 10.1093/glycob/cwr048. Epub 2011 Apr 5.
2
The Tn antigen-structural simplicity and biological complexity.Tn 抗原——结构简单而生物学特性复杂。
Angew Chem Int Ed Engl. 2011 Feb 18;50(8):1770-91. doi: 10.1002/anie.201002313. Epub 2011 Jan 21.
3
Random glycopeptide bead libraries for seromic biomarker discovery.随机糖肽珠库用于血清生物标志物的发现。
J Proteome Res. 2010 Dec 3;9(12):6705-14. doi: 10.1021/pr1008477. Epub 2010 Nov 2.
4
A high-throughput O-glycopeptide discovery platform for seromic profiling.高通量 O-糖肽发现平台用于血清蛋白质组分析。
J Proteome Res. 2010 Oct 1;9(10):5250-61. doi: 10.1021/pr1005229.
5
Antibody recognition of a unique tumor-specific glycopeptide antigen.抗体对一种独特的肿瘤特异性糖肽抗原的识别。
Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10056-61. doi: 10.1073/pnas.0915176107. Epub 2010 May 17.
6
Quantitative comparison of HTLV-1 and HIV-1 cell-to-cell infection with new replication dependent vectors.定量比较新型复制依赖性载体中 HTLV-1 和 HIV-1 的细胞间感染。
PLoS Pathog. 2010 Feb 26;6(2):e1000788. doi: 10.1371/journal.ppat.1000788.
7
Isolation and characterization of antibodies against three consecutive Tn-antigen clusters from a phage library displaying human single-chain variable fragments.从噬菌体文库中展示人源单链可变片段的三个连续 Tn 抗原簇分离并鉴定抗体。
J Biochem. 2010 Jun;147(6):809-17. doi: 10.1093/jb/mvq014. Epub 2010 Feb 10.
8
Anti-carbohydrate antibodies of normal sera: findings, surprises and challenges.正常血清中的抗碳水化合物抗体:发现、意外与挑战。
Mol Immunol. 2009 Sep;46(15):3037-49. doi: 10.1016/j.molimm.2009.06.010. Epub 2009 Jul 15.
9
A newly generated functional antibody identifies Tn antigen as a novel determinant in the cancer cell-lymphatic endothelium interaction.一种新产生的功能性抗体将Tn抗原鉴定为癌细胞与淋巴管内皮细胞相互作用中的一种新型决定因素。
Glycobiology. 2009 Oct;19(10):1056-67. doi: 10.1093/glycob/cwp085. Epub 2009 Jun 15.
10
Resolving conflicting data on expression of the Tn antigen and implications for clinical trials with cancer vaccines.解决关于Tn抗原表达的相互矛盾的数据及其对癌症疫苗临床试验的影响。
Mol Cancer Ther. 2009 Apr;8(4):971-9. doi: 10.1158/1535-7163.MCT-08-0934.